With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

If you miss the October vaccination window, there is still plenty of time to get protected before Thanksgiving. With ...

Electronic medical records of 42 children with SCD diagnosed between 2009 and 2023 were retrospectively reviewed. Clinical demographic data and pneumococcal serologies were analysed. Of the 42 ...

Inventprise, a Redmond, Wash.–based biotechnology company developing vaccines for infectious diseases, is laying off ...

Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

This recommendation follows a new study suggesting that the shingles vaccine may do more than just prevent a painful viral rash — it could also significantly reduce the risk of heart disease, dementia ...

Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...

Pneumococcal disease poses a severe risk to Indian adults, particularly those with chronic health issues. Despite effective ...

RESIDENTS are being urged to take up the flu and Covid-19 vaccine as the winter weather sets in. The council says getting ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 study titled ‘A Study to Learn About ...

The United States Adult Vaccine Market is projected to soar to US$ 11.10 billion by 2033, up from US$ 6.55 billion in 2024, ...